See all the latest news, blogs and updates from the medical sector.
SMC final review approves life-changing gene therapy for treating MLD
We are delighted to announce that the SMC has recently undertaken its final review of atidarsagene autotemcel (Libmeldy®) and has given a positive recommendation for its use within NHS Scotland.
Our summer of '26: proms, day trips, festivals and ice-cream
Maddi's mum Shelly looks back at their fun-filled summer months and all the great memories they have made together with family and friends.
A new chapter for Sophie
Since recently stepping into the role of Interim CEO, Sophie Thomas reflects on her journey with the MPS Society so far and explains her commitment for her next chapter with the charity.
Fabrazyme supply update for our Fabry community
We are sharing an update about the supply of Fabrazyme. You may already be aware that the FDA has raised concerns following a review of Sanofi’s manufacturing site in Ireland and we understand that uncertainty about treatment can be unsettling.
Regulatory update on RGX-121 for MPS II Hunter
Regenxbio have today issued an announcement about its investigational gene therapy RGX-121 for MPS II Hunter syndrome.
MPS Society CEO steps back after a decade supporting rare disease communities
After nearly a decade at the helm of the MPS Society, our Group CEO, Bob Stevens, has announced that he will take a step back from his role at the end of this year.
Generation Study update: implications for our expanded UK newborn screening panel work
We wanted to share an important update with our community about the Generation Study and what the completion of this research programme means for the future of newborn screening.
PPPN: working together
The PPPN is working together to improve care and outcomes for people living with Lysosomal Storage Disorders
Our response to the Timms Review of Personal Independence Payment (PIP)
The publication of the Timms Review marks an important moment in the future of Personal Independence Payment (PIP), with the review concluding that the current system is not fit for purpose.
Ambassador stories from the International MPS Symposium
Alison and Bethanie from the Patient Services Team were excited to be joined by our ambassadors Sam, Jacob and Helen in Florence. Together they reflect on their experience and share some core messages from the presentations they attended.